The goal of this systematic analysis is to provide a comprehensive review of the current cardiac magnetic resonance data on microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH). Data related to the association of MVO and IMH in patients with acute myocardial infarction (MI) with left ventricular (LV) function, volumes, adverse LV remodeling, and major adverse cardiac events (MACE) were critically analyzed. MVO is associated with a lower ejection fraction, increased ventricular volumes and infarct size, and a greater risk of MACE. Late MVO is shown to be a stronger prognostic marker for MACE and cardiac death, recurrent MI, congestive heart failure/heart failure hospitalization, and follow-up LV end-systolic volumes than early MVO. IMH is associated with LV remodeling and MACE on pooled analysis, but because of limited data and heterogeneity in study methodology, the effects of IMH on remodeling require further investigation. (J Am Coll Cardiol Img 2014;7:940-52)
I
n the setting of an acute myocardial infarction (MI), persistence of coronary artery occlusion for >40 min can lead to irreversible myocardial damage that spreads as a "wave front phenomenon" progressing from endocardium to epicardium (1,2).
Although timely reperfusion is presently the best mechanism to salvage ischemic myocardium and MVO begins in the infarcted core and can increase in size for up to 48 h (9) . MVO is reported to be present in up to 84% of the patients after ST-segment elevation myocardial infarction (STEMI) (10) (11) (12) . The diagnosis of MVO can be made using angiography (13, 14) , echocardiography (15) , nuclear scintigraphy (16) , myocardial contrast echocardiography (17) , or CMR. On angiography, microvascular blood flow is assessed using Thrombolysis In Myocardial Infarction flow grades, myocardial blush grade, and/ or corrected Thrombolysis In Myocardial Infarction frame count. The rate of myocardial uptake of microbubbles using contrast echocardiography has been used to assess MVO; however, this technique is limited by challenges of adequate acoustic windows, injection of microbubble contrast, and operator dependency (17) . There are limited data using single photon emission computed tomography, and this has been used only in research applications (16) . Of the available modalities, CMR provides the most comprehensive assessment of MVO.
MVO is detected on gadolinium-enhanced CMR as delayed or absent wash-in of contrast agent into the infarct zone. MVO as assessed by CMR is defined as "early" or "late" in reference to the timing of imaging relative to gadolinium administration ( Figure 1 ). Early microvascular obstruction (EMVO) is identified by a prolonged perfusion defect on resting first-pass perfusion (FPP) imaging (18) or as a hypointense region in the core of the infarct on T1-weighted images obtained 2 to 5 min after contrast administration (19) . Although FPP images have lower signal-to-noise ratio, spatial coverage, and ventricular coverage, a study comparing this technique with early T1-W imaging demonstrated concordance in 92% (20) .
Depending on the severity of MVO, the absence of wash-in of gadolinium may persist for >10 min (21), resulting in a region of persistent hypoenhancement within the core of the infarct on conventional late gadolinium enhancement images, referred to as "late MVO" (LMVO). Late gadolinium enhancement imaging used for LMVO assessment has high spatial and contrast resolution (22) and enables full coverage of the LV myocardium. Because the wash-in of gadolinium into the infarct core is a dynamic process (23, 24) , it is presently unknown whether the rate of fill-in of the MVO area has prognostic importance and whether EMVO or LMVO is a better predictor of LV remodeling or MACE.
INTRAMYOCARDIAL HEMORRHAGE. IMH is considered a severe form of MVO and follows MVO development in the core of the infarct (25-27) with a tendency to expand for several hours after percutaneous coronary intervention (28, 29) . The cause includes vascular endothelial damage and accumulation of red blood cells in the myocardial extracellular space (30) (31) (32) (33) (34) . It has been debated whether IMH is the cause or result of severe ischemic reperfusion injury (35) . Hamirani et al.
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METHODS
We conducted a systematic review by searching We assessed the association of presence of EMVO or LMVO on clinical outcomes of MACE, cardiac Hamirani et al.
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was assessed with the I2 statistic, and funnel plots were performed to assess for publication bias. No formal meta-regression was performed to explore heterogeneity because of the variation in reporting of important covariates and the scope of this review.
RESULTS
The pooled mean prevalence of EMVO, LMVO, and IMH in the studies reviewed was 65% (95% CI:
63% to 66%), 54% (95% CI: 52% to 56%), and 35% (95% CI: 31% to 38%), respectively (Online Table 1 ).
Some of the variability in the prevalence of MVO between studies may be due to differences in study populations, contrast doses, pulse sequences, The majority of the studies identified EMVO to be independently associated with LV remodeling and MACE (12, 19, 20, 24, 25, 50, 53, (55) (56) (57) (58) (59) (60) (61) (62) . The pooled analysis is presented in Table 1 , Figure 6 , and Online Tables 5A to 5D ). The majority of these studies demonstrate an effect of LMVO on both LV remodeling and MACE in multivariate analysis Tau Thus, EMVO is generally considered more sensitive (60, 61) , whereas LMVO is more specific for diagnosing microvascular damage (57, 85) . A high correlation is noted between EMVO and LMVO with correlation coefficients in the range of 0.52 to 0.78 (56,73).
In our meta-analysis of the data from 3 studies directly comparing EMVO and LMVO in the same patients, LMVO had a statistically higher odds ratios for predicting MACE (delta odds ratio: 2.56, Tau Figure 6 . 3.6 to 21.1; p < 0.001). The comparative sensitivity, specificity, and accuracy of EMVO versus LMVO for the prediction of MACE were 86%, 36%, and 48% versus 84%, 65%, and 70%, respectively, in this study.
EFFECT OF IMH ON LV REMODELING AND MACE. We identified 9 studies (1,106 patients) that examined the relationship between IMH and LV remodeling. The pooled mean differences in indexed volumes, IS, and EF between subjects with and without IMH are presented in Table 2 and demonstrate that IMH is associated with larger volumes, reduced EF, and increased IS.
There was variability in the imaging techniques used to assess IMH, and most studies have used T2-weighted STIR imaging, rather than T2* pulse sequences. Only 1 study (54) used both T2 and T2* to assess IMH, which was defined as present only when both T2 and T2* were positive. Two other studies (27, 86) used T2* only. IMH was seen predominantly in anterior infarcts (27) and in infarcts involving >80% of LV thickness (86) . O'Regan et al. (86) showed significantly reduced LVEF and increased LV volumes in patients with IMH on univariate analysis and a strong collinearity of IMH and MVO, whereas Ochiai et al. (27) Likewise, IMH was not a predictor of baseline or follow-up LVEF in multivariate analysis in other studies (75, 88) . Thus, it is not entirely clear whether IMH will have significant incremental utility for predicting IS, ventricular volumes, and functions in models that include other parameters of the infarct or LV structural/functional parameters. Without a larger head-to-head study using both T2-W and T2* techniques, it is difficult to determine which technique has superior performance for detecting IMH.
Three studies, using T2 STIR (81, 89, 90) , including a total of 991 patients with a follow-up of 6 months to 
